<div class="home-view">
  <div class="row">
    <div class="col-xs-12 col-sm-6 discover">
      <div class="row">
        <div class="col-sm-12 col-md-6 icon">
          <a ui-sref="browse.variants">
            <img src="assets/images/icon_discover.svg" alt="Discover" class="img-responsive"/>
          </a>
        </div>
        <div class="col-sm-12 col-md-6 blurb">
          <p>Discover supported clinical interpretations of mutations related to cancer.</p>
        </div>
      </div>
    </div>
    <div class="col-xs-12 col-sm-6 collaborate">
      <div class="row">
        <div class="col-sm-12 col-md-6 icon">
          <a ui-sref="participate">
            <img src="assets/images/icon_collaborate.svg" alt="Discover" class="img-responsive" width="90%"/>
          </a>
        </div>
        <div class="col-sm-12 col-md-6 blurb">
          <p>Participate with colleagues to add variants and support for cancer-related mutations.</p>
        </div>
      </div>
    </div>
  </div>
  <div class="row" style="margin-top: 16px;">
    <div class="col-xs-12 intro-block">
      <div class="row">
        <div class="col-xs-6">
          <div class="intro">
            <h4>The Precision Medicine Revolution</h4>
            <p>Precision medicine refers to the use of prevention and treatment strategies that are tailored to the unique features of each individual and their disease. In the context of cancer this might involve the identification of specific mutations shown to predict response to a targeted therapy. The biomedical literature describing these associations is large and growing rapidly. Currently these interpretations exist largely in private or encumbered databases resulting in extensive repetition of effort.</p>
          </div>
        </div>
        <div class="col-xs-6">
          <div class="intro">
            <h4>CIViC's Role in Precision Medicine</h4>
            <p>Realizing precision medicine will require this information to be centralized, debated and interpreted for application in the clinic. <strong>CIViC is an open access, open source, community-driven web resource for Clinical Interpretation of Variants in Cancer.</strong> Our goal is to enable precision medicine by providing an educational forum for dissemination of knowledge and active discussion of the clinical significance of cancer genome alterations. For more details refer to the 2017 <a href=http://www.nature.com/ng/journal/v49/n2/full/ng.3774.html>CIViC publication</a> in Nature Genetics.</p>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div class="row" >
    <div class="col-xs-12 section-header" >
      <h4>Announcements</h4>
      <hr/>
    </div>
  </div>
   <div class="row" >
    <div class="col-xs-12 col-md-6" >
      <div class="announcement" >
        <div class="announcement-banner" >
          <a href="https://civic.genome.wustl.edu/users/48/profile">
            <img src="assets/images/partners/asco-import-banner_v1b.jpg" class="img-responsive" width="1080"  height="169"/>
          </a>
        </div>
        <div class="announcement-body" style="margin-bottom: 1em;">
          <p class="date">June 2nd, 2017</p>
          <p><span style="color:#faa51b;">The American Society of Clinical Oncology, Inc. (ASCO) and Illumina, Inc. (Illumina) make a joint contribution of predictive associations between somatic genetic alterations and commercially available drugs.</span> These associations were curated by Illumina's <a href="https://civic.genome.wustl.edu/users/48/profile">Biomedical Informatics team</a> for ASCO's ground-breaking <a target="_blank" href="https://www.tapur.org/">Targeted Agent and Profiling Utilization Registry (TAPUR)</a> clinical study. All submissions have been entered in a pending state and will be subjected to review by CIViC's expert editorial team.</p>
        </div>
      </div>
    </div>
    <div class="col-xs-12 col-md-6" >
      <div class="announcement" >
        <div class="announcement-banner" >
          <a href="https://civic.genome.wustl.edu/users/48/profile">
            <img src="assets/images/partners/illumina-import-banner_v1b.jpg" class="img-responsive" width="1080"  height="169"/>
          </a>
        </div>
        <div class="announcement-body" style="margin-bottom: 1em;">
          <p class="date">April 3rd, 2017</p>
          <p><span style="color:#faa51b;">Illumina Inc. makes a significant donation of somatic variant interpretations to the CIViC project.</span> This generous donation makes Illumina Inc. the largest single contributor to the CIViC project to date. The donation includes thousands of associations of therapeutic value, with evidence gathered from publications and drug labels by scientists in the <a href="https://civic.genome.wustl.edu/users/48/profile">Biomedical Informatics team</a> at Illumina Inc. All submissions have been entered in a pending state and will be subjected to review by CIViCâ€™s expert editorial team.</p>
        </div>
      </div>
    </div>
  </div>
  <div class="row">
    <div class="col-xs-12 col-sm-6 stats-block">
      <div class="row">
        <div class="col-xs-12">
          <h4>Database and Community Statistics</h4>
        </div>
      </div>
      <div class="row">
        <stats-block
          stats="vm.stats.genes"
          title="Genes"
          icon-url=""
          cols="col-xs-4">
        </stats-block>
        <stats-block
          stats="vm.stats.variants"
          title="Variants"
          icon-url=""
          cols="col-xs-4">
        </stats-block>
        <stats-block
          stats="vm.stats.evidence_items"
          title="Evidence Items"
          icon-url=""
          cols="col-xs-4">
        </stats-block>
      </div>
      <div class="row" style="margin-top: 16px;">
        <stats-block
          stats="vm.stats.drugs"
          title="Drugs"
          icon-url=""
          cols="col-xs-4">
        </stats-block>
        <stats-block
          stats="vm.stats.diseases"
          title="Diseases"
          icon-url=""
          cols="col-xs-4">
        </stats-block>
        <stats-block
          stats="vm.stats.sources"
          title="Publications"
          icon-url=""
          cols="col-xs-4">
        </stats-block>
      </div>
      <div class="row" style="margin-top: 16px;">
        <stats-block
          stats="vm.stats.suggested_changes"
          title="Revisions"
          icon-url=""
          cols="col-xs-4">
        </stats-block>
        <stats-block
          stats="vm.stats.users"
          title="Contributors"
          icon-url=""
          cols="col-xs-4">
        </stats-block>
        <stats-block
          stats="vm.stats.comments"
          title="Comments"
          icon-url=""
          cols="col-xs-4">
        </stats-block>
      </div>
    </div>
    <div class="col-xs-12 col-sm-6 stats-block">
      <div class="row">
        <div class="col-xs-12">
          <h4>CIViC Activity</h4>
        </div>
      </div>
      <div class="row">
        <div class="col-xs-12">
          <ul class="events">
            <li ng-repeat="event in vm.events | limitTo:6">
              <event-item event="event" theme="'dark'">EVENT</event-item>
            </li>
            <li>
              <a class="btn btn-default btn-xs btn-block" ui-sref="activity">
                View All Activity&nbsp;<i class="glyphicon glyphicon-arrow-right"></i>
              </a>
            </li>
          </ul>

        </div>
      </div>
    </div>
  </div>
  <div class="row" style="margin-top: 32px;">
    <div class="col-xs-12 disclaimer-block">
      <div class="disclaimer small">
        <p><strong>Medical Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.</strong></p>
        <p>CIViC is a community-edited forum for discussion and interpretation of peer-reviewed publications pertaining to the clinical relevance of variants (or biomarker alterations) in cancer. These interpretations may include associations between molecular alterations (or lack of alteration) and one or more drugs, diagnoses, prognoses or other treatment decisions. These interpretations of clinical significance (or lack of clinical significance) are purely for research purposes. A finding of no interpretation does not necessarily indicate lack of relevance for any specific variant or biomarker alteration. Interpretations are not presented in ranked order of potential or predicted importance.These interpretations make no promise or guarantee of any clinical benefit (or lack of clinical benefit).</p>
        <p>The civicdb.org (civic.genome.wustl.edu) website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. <strong>IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY</strong>. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.</p>
      </div>
    </div>
  </div>
</div>
